DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Choriogonadotropin alfais the generic ingredient in one branded drug marketed by Emd Serono and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
Choriogonadotropin alfa has eighteen patent family members in fourteen countries.
One supplier is listed for this compound.
Recent Clinical Trials for choriogonadotropin alfa
Identify potential brand extensions & 505(b)(2) entrants
|Sheba Medical Center||Phase 4|
|One Fertility||Phase 2|
|Seoul National University Hospital||N/A|
Pharmacology for choriogonadotropin alfa
|Drug Class||Gonadotropin |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Emd Serono||OVIDREL||choriogonadotropin alfa||INJECTABLE;SUBCUTANEOUS||021149-002||Oct 6, 2003||RX||Yes||Yes||Start Trial||Start Trial||Y||Start Trial|
|Emd Serono||OVIDREL||choriogonadotropin alfa||INJECTABLE;INJECTION||021149-001||Sep 20, 2000||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Emd Serono||OVIDREL||choriogonadotropin alfa||INJECTABLE;INJECTION||021149-001||Sep 20, 2000||Start Trial||Start Trial|
|Emd Serono||OVIDREL||choriogonadotropin alfa||INJECTABLE;SUBCUTANEOUS||021149-002||Oct 6, 2003||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|0487512||SPC/GB01/030||United Kingdom||Start Trial||PRODUCT NAME: RECOMBINANT CHORIOGONADOTROPIN ALFA; REGISTERED: UK EU/1/00/165/001-006 20010202|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.